Displaying drugs 2326 - 2350 of 2778 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Cefpirome | 514.577 C22H22N6O5S2 |  | An antibiotic indicated in the treatment of a wide variety of infections in the body. | Anti-Bacterial Agents / beta Lactam Antibiotics / Fourth-Generation Cephalosporins |
| Telmisartan | 514.6169 C33H30N4O2 |  | An ARB used to treat hypertension, diabetic nephropathy, and congestive heart failure. | Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics |
| Taurocholic acid | 515.703 C26H45NO7S |  | The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats... | Bile Acids and Salts / Cholagogues and Choleretics / Cholic Acids / Detergents / Gastrointestinal Agents / Steroids |
| Siponimod | 516.605 C29H35F3N2O3 |  | A medication used to treat relapsing multiple sclerosis. | Selective Immunosuppressants |
| Udenafil | 516.656 C25H36N6O4S |  | A PDE5 inhibitor used to treat erectile dysfunction. | Drugs Used in Erectile Dysfunction |
| Fusidic acid | 516.7092 C31H48O6 |  | A topical antibacterial agent used to prevent and treat mild to moderate skin infections caused by susceptible bacteria. | Medicated Dressings With Antiinfectives / Steroid Antibacterials |
| Probucol | 516.842 C31H48O2S2 |  | Used to lower LDL and HDL cholesterol. | Anticholesteremic Agents / Antioxidants / Phenols |
| Piperacillin | 517.555 C23H27N5O7S |  | A penicillin antibiotic combined with tazobactam to treat piperacillin-resistant, piperacillin/tazobactam susceptible, β-lactamase generating strains of several bacteria. | Penicillins With Extended Spectrum |
| Retapamulin | 517.763 C30H47NO4S |  | A topical antibiotic agent used for the treatment of impetigo caused by methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes. | Anti-Bacterial Agents / Pleuromutilin Antibacterial |
| Benziodarone | 518.089 C17H12I2O3 |  | Benziodarone is a uricostatic and a uricosuric agent which is sold also under the name Amplivex-Labaz. It is used in the treatment of gout . It was withdrawn from France... | Uricosuric Agents |
| Dichloralphenazone | 519.032 C15H18Cl6N2O5 |  | Dichloralphenazone is a sedative composed of chloral hydrate and phenazone. It is typically found in combination products Nodolor and Midrin containing isometheptene and acetaminophen used for the relief of tension... | Alcohols / Central Nervous System Depressants / Ethylene Glycols / Glycols / Hypnotics and Sedatives / Nervous System / Psycholeptics / Pyrazoles / Pyrazolones |
| Tenofovir disoproxil | 519.448 C19H30N5O10P |  | A nucleotide analog reverse transcriptase inhibitor used in the treatment of Hepatitis B infection and used in the management of HIV-1 infection. | Anti-HIV Agents / Antiviral Agents / Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor / Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor / Nucleoside and Nucleotide Reverse Transcriptase Inhibitors / Reverse Transcriptase Inhibitors |
| Ceforanide | 519.554 C20H21N7O6S2 |  | For the treatment of infections caused by susceptible organisms. | Anti-Bacterial Agents / Second-Generation Cephalosporins |
| Dabrafenib | 519.562 C23H20F3N5O2S2 |  | A kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors |
| Boceprevir | 519.6767 C27H45N5O5 |  | A hepatitis C virus NS3/4A protease inhibitor used in combination with other medications to treat chronic hepatitis C genotype 1 infection. Boceprevir is not indicated as monotherapy. | Antivirals for treatment of HCV infections / Protease Inhibitors |
| Estramustine phosphate | 520.38 C23H32Cl2NO6P |  | A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties. | Antineoplastic Agents, Alkylating / Antineoplastic Agents, Hormonal / Nitrogen Mustard Compounds |
| Latamoxef | 520.473 C20H20N6O9S |  | Latamoxef is an oxacephem antibiotic usually grouped with the cephalosporins. It is used to treat bacterial infections. Latamoxef is primarily indicated in conditions like Bone and joint infection, GI infections,... | Anti-Bacterial Agents / Third-Generation Cephalosporins |
| Tezacaftor | 520.505 C26H27F3N2O6 |  | A medication used to treat homozygous or heterozygous F508del mutation cystic fibrosis. | BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Inducers / Cytochrome P-450 CYP3A5 Inducers (strength unknown) / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Dioxoles / Heterocyclic Compounds, Fused-Ring / OAT1/SLC22A6 inhibitors / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B1/SLCO1B1 Substrates / OATP1B3 inhibitors / OCT2 Inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates |
| Ciprocinonide | 520.57 C28H34F2O7 |  | Not Annotated | Not Annotated |
| Omidenepag isopropyl | 520.61 C26H28N6O4S |  | An agonist of the prostaglandin EP2 receptor indicated for the reduction of elevated intraocular pressure. | Antiglaucoma Agents / Hypotensive Agents / Ophthalmic Solutions / Ophthalmics / Prodrugs / Pyrazoles / Pyridines / Receptors, Prostaglandin E, EP2 Subtype, agonists / Sulfonamides |
| Beclomethasone dipropionate | 521.042 C28H37ClO7 |  | An inhaled corticosteroid used as maintenance treatment in the prophylaxis of asthma attacks. | Corticosteroids Acting Locally / Corticosteroids, Potent (Group III) / Glucocorticoids |
| Mometasone furoate | 521.429 C27H30Cl2O6 |  | A corticosteroid used to treat asthma, allergic rhinitis, nasal congestion, nasal polyps, dermatitis, and pruritus. | Corticosteroids, Potent (Group III) / Glucocorticoids |
| Ticagrelor | 522.568 C23H28F2N6O4S |  | A P2Y12 platelet inhibitor used in patients with a history of myocardial infarction or with acute coronary syndrome (ACS) to prevent future myocardial infarction, stroke and cardiovascular death. | Platelet Aggregation Inhibitors Excl. Heparin |
| Diacetyl benzoyl lathyrol | 522.638 C31H38O7 |  | Diacetyl benzoyl lathyrol is an active ingredient in whitening creams. It is also reported to be a skin conditioning agent. | Not Annotated |
| Fedratinib | 524.678 C27H36N6O3S |  | Fedratinib is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.[L8090,L47016] | Janus Kinase Inhibitor / Protein Kinase Inhibitors |
Displaying drugs 2326 - 2350 of 2778 in total